
NYSEHealthcareMedical - Devices
ข้อมูลล่าสุด
US$99.60
+US$1.11 · +1.13%
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
ราคาปิดก่อนหน้า
US$99.60
+US$1.11 · +1.13%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
ช่วงราคารายวัน
ปัจจุบัน US$99.60
ช่วง 52 สัปดาห์
ปัจจุบัน US$99.60
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ซื้อ
มูลค่า
83
มูลค่าน่าสนใจมาก
ความเชื่อมั่น
72
เชิงบวก
ความเสี่ยง
31
ความเสี่ยงปานกลาง
โมเมนตัม
38
กำลังอ่อนตัว
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
ช่วงราคารายวัน
ปัจจุบัน US$99.60
ช่วง 52 สัปดาห์
ปัจจุบัน US$99.60
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 44.33B USD | 41.95B USD | 40.11B USD | 43.65B USD | 43.08B USD |
| ต้นทุนสินค้าขาย | 19.72B USD | 20.63B USD | 20.07B USD | 21.33B USD | 19.86B USD |
| กำไรขั้นต้น | 24.61B USD | 21.33B USD | 20.04B USD | 22.32B USD | 23.21B USD |
| การวิจัยและพัฒนา | 2.96B USD | 2.82B USD | 2.72B USD | 2.85B USD | 2.74B USD |
| การขาย ทั่วไป และธุรการ | 12.38B USD | 11.65B USD | 10.88B USD | 11.11B USD | 11.28B USD |
| ค่าใช้จ่ายในการดำเนินงาน | 16.59B USD | 14.47B USD | 13.6B USD | 13.96B USD | 14.01B USD |
| รายได้ดอกเบี้ย | 230M USD | 344M USD | 385M USD | 183M USD | 43M USD |
| ดอกเบี้ยจ่าย | 341M USD | 603M USD | 698M USD | 315M USD | 410M USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 3.12B USD | 3.22B USD | 3.24B USD | 3.27B USD | 3.54B USD |
| รายได้จากการดำเนินงาน | 8.05B USD | 6.83B USD | 6.44B USD | 8.36B USD | 9.2B USD |
| รายได้สุทธิ | 6.52B USD | 13.4B USD | 5.72B USD | 6.93B USD | 7.07B USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 11 ต.ค. 2569.
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
| รายการ | วันที่มีผลบังคับใช้ | รายละเอียด | วันกำหนดรายชื่อ | วันจ่ายเงิน |
|---|---|---|---|---|
การแยกหุ้น | 2 ม.ค. 2556 | 5,000:2,399 | — | — |
การแยกหุ้น | 3 พ.ค. 2547 | 2,500:2,339 | — | — |
การแยกหุ้น | 1 มิ.ย. 2541 | 2:1 | — | — |
การแยกหุ้น | 1 มิ.ย. 2535 | 2:1 | — | — |
การแยกหุ้น | 1 มิ.ย. 2533 | 2:1 | — | — |
การแยกหุ้น | 2 มิ.ย. 2529 | 2:1 | — | — |
มีผลแล้ว 2 ม.ค. 2556
5,000:2,399
มีผลแล้ว 3 พ.ค. 2547
2,500:2,339
มีผลแล้ว 1 มิ.ย. 2541
2:1
มีผลแล้ว 1 มิ.ย. 2535
2:1
มีผลแล้ว 1 มิ.ย. 2533
2:1
มีผลแล้ว 2 มิ.ย. 2529
2:1
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
State Street SPDR S&P 500 ETF1557.T329.31B0.25%129.35T JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI6.11B0.26%2.3T USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO5.11B0.29%1.8T USD0.03%US$715.59+0.61%
Schwab U.S. Dividend Equity ETFSCHD4.12B3.74%110.32B USD0.06%US$33.04-0.32%
iShares Core S&P 500 ETFIVV2.27B0.25%896.44B USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY2.08B0.25%817.2B USD0.09%US$778.57+0.60%
Vanguard Morningstar Value ETFVTV1.84B0.70%262.4B USD0.03%US$220.59+0.44%
State Street Health Care Select Sector SPDR ETFXLV1.21B2.79%43.54B USD0.08%US$170.81+1.58%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Schwab U.S. Dividend Equity ETFSCHD
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLVเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน